Skip to main content
SpringerLink
Log in

Literaturverzeichnis

  • Chapter
Die Virushepatitiden

  • 28 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. Dittmann S, Hallauer J. Aktuelle Trends der Hepatitis-B-Prävention in Ländern mit niedriger HBsAg-Prävalenz. In: Maas G, Stück B (Hrsg.). Virus-Hepatitis A bis E, Kongreßberichte des Deutschen Grünen Kreuzes. Kilian: Marburg 1994.

    Google Scholar 

  2. Deinhardt F. Selecta 1983: 1185–1188.

    Google Scholar 

  3. Lange W, Masihi K. Epidemiologische und ökonomische Bedeutung der Hepatitis B in der Bundesrepublik Deutschland. Postgrad Med 1987; 63 (Suppl. 2): 21–26.

    Google Scholar 

  4. World Health Organization. Erworbenes Immundefekt-Syndrom (AIDS), Daten v. 01.07.1992. Wkly Epidemiol Rec 1992; 67: 201–203.

    Google Scholar 

  5. World Health Organization. Hepatitis B vaccine set for introduction into national immunisation programmes. WHO Press 21. 02. 1992.

    Google Scholar 

  6. Morgan D. HIV and needlestick injuries. Lancet 1990; 336: 1280.

    Article  Google Scholar 

  7. Marcus R. Surveilliance of healthcare workers exposed to blood from patients infected with human immunodeficiency virus. N Engl J Med 1988; 319: 1118–1123.

    Article  PubMed  CAS  Google Scholar 

  8. Hu DJ, et al. Transmission of HIV, Hepatitis B virus and other blood-borne disease in healthcare settings. Bull World Health Organ 1991; 69 (5): 623630.

    Google Scholar 

  9. Bell DM, et al. Risk of Hepatitis B and human immunodeficiency virus transmission from an infected surgeon due to percutaneous injury during an invasive procedure. Infect Agents Dis 1992; 1 (5): 263–269.

    PubMed  CAS  Google Scholar 

  10. Toukan A. Strategy for the control of hepatitis B virus infection in the Middle East and North Africa. Vaccine 1990; (Suppl.): 117–128.

    Google Scholar 

  11. Kiire CF. The epidemiology and control of hepatitis B in sub-Saharan Africa. Prog Med Virol 1993; 40: 141–156.

    PubMed  CAS  Google Scholar 

  12. Sobeslavsky O. Prevalence of markers of hepatitis B virus infection in various countries: a WHO coll. study. Bull World Health Organ 1980; 58: 621–628.

    PubMed  CAS  Google Scholar 

  13. Szmuness W. Recent advances in the study of the epidemiology of hepatitis B. Am J Path 1975; 81: 629–650.

    PubMed  CAS  Google Scholar 

  14. Cockburn WC. The epidemiology of hepatitis B infection in Europe. In: KRUGMAN S, et al. Proceedings of the European Symposium on Hepatitis B. Rahway: New Yersey. Merck Sharp & Dohme Int. 1981; 5–16.

    Google Scholar 

  15. Scott RM. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis 1980; 142: 67–71.

    Article  PubMed  CAS  Google Scholar 

  16. Akdamar KA, et al. SH antigen in bile. Lancet 1971; 1: 909.

    Article  PubMed  CAS  Google Scholar 

  17. Villarejos VM, et al. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med 1974; 291: 1375–1378.

    Article  PubMed  CAS  Google Scholar 

  18. Darrell RW, Jacob GB. Hepatitis B surface antigen in human tears. Arch Ophthalmol 1978; 96: 674–676.

    Article  PubMed  CAS  Google Scholar 

  19. Darani M, Gerber M. Hepatitis B antigen in vaginal secretions. Lancet 1974; 2: 1008.

    Article  PubMed  CAS  Google Scholar 

  20. Hallauer JF, Rasch G. Epidemiology of Hepatitis B in Germany. In: BENNETT DL (Hrsg.). The Control of Hepatitis B: The Role of Prevention in Adolescence. Gower Medical Publishing: London 1991.

    Google Scholar 

  21. Maier KP. Hepatitis — Hepatitisfolgen. 3. Aufl. Thieme: Stuttgart, New York 1991.

    Google Scholar 

  22. Choo V. Jail for putting patients at risk of hepatitis B. Lancet 1994; 344 (2): 144–151.

    Google Scholar 

  23. Strohmeyer G, et al. Therapie der chronischen Virus-Hepatitis mit Alpha-Interferon. Deutsches Ärzteblatt 1993; 90(12): C-562–564.

    Google Scholar 

  24. Maruna H. Zur Hepatitis-B-Durchseuchung in den Berufen des Gesundheits-und Fürsorgewesens der Republik Österreich. Arbeitsmed Sozialmed Präventivmed1990; 25: 71–75.

    Google Scholar 

  25. Hofmann F, et al. Zur Hepatitis-B-Gefährdung der Beschäftigten im Gesundheitsdienst. Arbeitsmed Sozialmed Präventivmed 1987; 22: 49–52.

    Google Scholar 

  26. Butz M, et al. Bk-Doc 81— Berufskrankheiten-Geschehen. Schriftenreihe des HV d. gewerbl. BG 1982.

    Google Scholar 

  27. Butz M, et al. BK-DOC 90 — Berufskrankheiten-Geschehen. Schriftenreihe des HV d. gewerbl. BG 1992.

    Google Scholar 

  28. Schreiermann N, Kuwert EK, Remy J. Hepatitis-B-Virus-Durchseuchung des medizinischen Personals in Arztpraxen. Dtsch Med Wochenschr 1985; 110: 180.

    Article  Google Scholar 

  29. Chriske HW, Bock HC, Clemens R. Immunantwort auf Nachimpfungen mit einer rekombinanten Hepatitis-B-Vakzine bei Low-und Non-Respondern. Arbeitsmed Sozialmed Präventivmed 1990; 25 (9): 421–422.

    Google Scholar 

  30. Schoppe WD, Kindler U, Waldorf. HBsAg und Anti HBs bei Krankenhauspersonal. Dtsch Med Wochenschr 1977; 102: 1712.

    Article  PubMed  CAS  Google Scholar 

  31. Vogt-Versloot G. An occupational hazard among nurses. In: Kane M, Holleran C, Andre M (Hrsg.). Proceedings–European Conference on hepatitis B as an occupational hazard. Genf 1990; 25–29.

    Google Scholar 

  32. Hasselhorn HM. Hepatitis-B-Impfung beim medizinischen Personal. MMW-Extrablatt 1994; 117: 1.

    Google Scholar 

  33. Clemens R. Prävalenz von Hepatitis A, B und C bei Bewohnern einer Einrichtung für geistig Behinderte. Sozialpädiatrie 1992; 14: 357–364.

    Google Scholar 

  34. Illichmann HR, Schmidt W, Plassmann E. Hepatitis-B-Impfung bei Pflegepersonal. Fortschr Med 1990; 22: 425–428.

    Google Scholar 

  35. Perrillo RP, et al. Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students. J Infect Dis 1984; 149: 796–800.

    Article  PubMed  CAS  Google Scholar 

  36. Remis RS, et al. Hepatitis B infection in a day school for mentally retarded students: transmission from students to staff. Am J Public Health 1987; 77: 1183–1186.

    Article  PubMed  CAS  Google Scholar 

  37. Hardman PK, et al. The incidence and prevalence of hepatitis B surface antibody in a dental school population. Oral Surg Oral Med Oral Pathol 1990; 69 (3): 399–402.

    Article  PubMed  CAS  Google Scholar 

  38. Schreiermann N, Kuwert EK. Zur Frage der Infektionsgefährdung medizinisch-technischer Assistentinnen durch das Hepatitis-B-Virus. Dtsch Med Wochenschr 1978; 103: 1065.

    Article  Google Scholar 

  39. Hamilton JD, et al. Transmission of hepatitis B by a human bite: an occupational hazard. Can Med Assoc J 1976; 115: 439–440.

    PubMed  CAS  Google Scholar 

  40. Dannibali E, et al. Policemen as a risk group for hepatitis B virus infection. International Symposium on Viral Hepatitis and Liver Disease: Houston, Texas 1990; Abstr. 222.

    Google Scholar 

  41. Hodgson ES, et al. Hepatitis B perceived risk factors in public sector employees. In: Coursaget P, Tong MJ, Hrsg. Progress in Hepatitis B immunisation. Paris 03.-05.05. 1989; 521–522.

    Google Scholar 

  42. Chiaramonte M, et al. Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg Epidemiol Microbiol Inununol 1982; 89: 53–58.

    CAS  Google Scholar 

  43. Gaube J, et al. Hepatitis A, B und C als desmoterische Infektionen. Gesundheitswesen 1993; 55: 246–249.

    PubMed  CAS  Google Scholar 

  44. Sefrin P, et al. Neue Risikogruppe: Rettungssanitäter. Munch Med Wochenschr 1988; (Beilage 66 ) 130.

    Google Scholar 

  45. Valenzuela TD, et al. Occupational exposure to hepatitis B in fire-figtherparamedics. Arch Intern Med 1985; 145: 1976–1977.

    Article  PubMed  CAS  Google Scholar 

  46. Chriske HW, et al. Hepatitis-B-Infektionsgefährdung bei Kanal-und Klärwerksarbeitern. Arbeitsmed Sozialmed Präventivmed 1990; 25: 475–477.

    Google Scholar 

  47. Steffen R. International Conference on Prospects for Eradication of Hepatitis-B-Virus. Genf 23.-24. 02. 1989.

    Google Scholar 

  48. Piot P. International Conference on Prospects for Eradication of Hepatitis-BVirus. Genf 23.-24. 02. 1989.

    Google Scholar 

  49. Meheus A. Hepatitis B: a serious sexually transmitted infection. Viral Immunol 1994; 2 (1): 6.

    Google Scholar 

  50. Hart G, et al. Risk factors of hepatitis B infection. Int J STD AIDS 1993; 4: 102–106.

    PubMed  CAS  Google Scholar 

  51. World Health Organization Features. Genf Schweiz 1992; 152.

    Google Scholar 

  52. Alter MJ, et al. Hepatitis B virus transmission between heterosexuals. J Am Med Wom Ass 1986; 256: 1307–1310.

    Article  CAS  Google Scholar 

  53. Murray-Lyon IM. Strategies for preventing hepatitis B. Q J Med 1989; 71: 277–278.

    PubMed  CAS  Google Scholar 

  54. Hess G, Gross G. Sexuelle Übertragung der Hepatitisviren. Hautarzt 1991; 42: 347–349.

    PubMed  CAS  Google Scholar 

  55. Alter MJ, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. J Am Med Worn Ass 1990; 263: 1218–1222.

    Article  CAS  Google Scholar 

  56. Inaba N, et al. Sexual transmission of hepatitis B surface antigen. Br J Vener Dis 1979; 55: 366–368.

    PubMed  CAS  Google Scholar 

  57. Papaevangelou G, et al. Post-exposure hepatitis B vaccination of sexual partners of acute viral hepatitis patients. J Infect 1983: 7 (Supp.): 63–67.

    Article  PubMed  Google Scholar 

  58. Piot P, Goilav C, Kegels E. Hepatitis B: transmission by sexual contact and needle sharing. Vaccine 1990; 8 (Supp.): 37–40.

    Article  Google Scholar 

  59. Henrietta MH, et al. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 406–410.

    Google Scholar 

  60. Niesert ST, Fritsch U, Schneider J. Hepatitis-B-Screening in der Schwangerschaft und Immunprophylaxe der Neugeborenen. Kinderärztl Prax 1993/94; 46: 273–279.

    Google Scholar 

  61. Feist D. Vertikale Transmission und Schutzimpfung gegen Hepatitis B. Monatsschr Kinderheilkd 1987; 135: 455–459.

    PubMed  CAS  Google Scholar 

  62. Hülsse C, et al. Untersuchungen zur vertikalen Transmission des HepatitisB-Virus. Z Ärztl Fortbild 1990; 84: 203–206.

    Google Scholar 

  63. Crovari P, Icardi GC, Bonanni P. Heterosexual transmission of HIV and HBV infection in Genoa, Italy. Abstracts of the 8th Meeting of the International Society for Sexually transmitted Diseases Research. Kopenhagen Dänemark 10.-13. 09. 1989; 43.

    Google Scholar 

  64. Bonanni P. Sharing home with carrier poses hepatitis B danger. Viral Hepatitis-News from the Hepatitis Prevention Board 1994; 2 (1): 8.

    Google Scholar 

  65. Laukamm-Josten U, Schönfeld C, Bienzle U. Warum impfen wir nicht häufiger gegen Hepatitis B? Therapiewoche 1990; 40: 2191–2194.

    Google Scholar 

  66. Franks AL. Hepatitis B infection among children born in the United States to southeast Asian refugees. N Engl J Med 1989; 321: 1301–1305.

    Article  PubMed  CAS  Google Scholar 

  67. Hall AJ. Hepatitis in travellers: epidemiology and prevention. Br Med Bull 1993; 49 (2): 382–393.

    PubMed  CAS  Google Scholar 

  68. Wylie BR. Transfusionsbedingte Infektionen. Diagnose u. Labor 1994; 44 (4): 149–156.

    Google Scholar 

  69. Grob P. The significance of hepatitis B infection in patients on hemodialysis or renal transplantation. In: KRUGMAN S, et al. Proceedings of the European Symposium on Hepatitis B. Rahway: New Yersey. Merck Sharp & Dohme Int. 1981; 39–53.

    Google Scholar 

  70. Shusterman N, Singer I. Infectious hepatitis in dialysis patients. Am J Kidney Dis 1987; IX: 447–450.

    Google Scholar 

  71. Gemeinsame Stellungnahme zum Problem der Übertragung von HIV durch Zahnärzte und Ärzte. Deutsches Ärzteblatt 1991; 88 (33): A-2692–2693.

    Google Scholar 

  72. Exner M. Zur HIV-Übertragung von medizinischem Personal auf Patienten. Hyg + Med 1991; 16: 457–462.

    Google Scholar 

  73. Chiarmonte M, Floreani A, Naccarato R. Hepatitis B virus infection in the elderly: an underestimated problem. Gut 1980; 21: A 443.

    Google Scholar 

  74. Szmuness W, et al. On the role of sexual behaviour in the spread of hepatitis B infection. Ann Intern Med 1975; 83: 489–495.

    PubMed  CAS  Google Scholar 

  75. Reiner NE, et al. Asymptomatic rectal mucosal lesions and hepatitis B surface antigen at sites of sexual contact in homosexual men with persistent hepatitis B virus infection. Ann Intern Med 1984; 96: 170–173.

    Google Scholar 

  76. Oleske J, et al. Transmission of hepatitis B in a classroom setting. J Pediatr 1980; 97: 770–772.

    Article  PubMed  CAS  Google Scholar 

  77. Laskus TE, et al. Prevalence of hepatitis B virus markers among Polish urban alcoholics. Infection 1988; 16: 354–357.

    Article  PubMed  CAS  Google Scholar 

  78. Hofmann F. Betriebsarzt im Krankenhaus. Ecomed: Landsberg 1992; 44.

    Google Scholar 

  79. Andre FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990; 8 (Supp.): 74–78.

    Article  Google Scholar 

  80. Engerix-B — Meeting the challenge of Hepatitis B. SmithKline Beecham Biologicals 1994.

    Google Scholar 

  81. Engerix-B — Basis-Information. SmithKline Beecham Pharma GmbH 1993.

    Google Scholar 

  82. Crovari P. Stand der Hepatitis-B-Prävention in Italien. Virus-Hepatitis — Aktuelle Nachrichten des Hepatitis Prevention Board; 2 (2): 11.

    Google Scholar 

  83. DE La Torre J. Stand der Hepatitis-B-Prävention in Spanien. Virus-Hepatitis — Aktuelle Nachrichten des Hepatitis Prevention Board; 2 (2): 11.

    Google Scholar 

  84. Gully P. Stand der Hepatitis-B-Prävention in Kanada. Virus-Hepatitis — Aktuelle Nachrichten des Hepatitis Prevention Board; 2 (2): 11.

    Google Scholar 

  85. Shapiro CR. Epidemiology of hepatitis B. Pediatr Infect Dis 1993; 12: 433–437.

    Article  CAS  Google Scholar 

  86. Maier KP. Die akute Hepatitis A. Thieme: Stuttgart, New York 1993.

    Google Scholar 

  87. Hofmann F. Hepatitis A in der Arbeitswelt. ecomed: Landsberg 1994.

    Google Scholar 

  88. Anomo-Studie, 1988–1994. Schriftenreihe d. Bundesministeriums für Gesundheit. Nomos 1996.

    Google Scholar 

  89. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine. Vol. 10. Suppl. 1, 1992.

    Google Scholar 

  90. Jill W. Diagnostik der Hepatitis A. In: HOFMANN F. Hepatitis A in der Arbeitswelt. ecomed: Landsberg 1994: 13–17.

    Google Scholar 

  91. Frösner GG. Hepatitis-A-Virus. In: Belshe RB (Hrsg.). Textbook of human virology, 2nd ed. Mosby Year Book: St. Louis 1991; 498–516.

    Google Scholar 

  92. Feinstone SM, et al. Hepatitis A: detection by immune electron microscopy of a virus like antigen associates with acute illness. Science 1973; 182: 1026–1028.

    Article  PubMed  CAS  Google Scholar 

  93. Coulepsis AG, et al. Evidence that the genome of hepatitis A virus consists of single-stranged RNA. J Virol 1981; 3: 473–477.

    Google Scholar 

  94. Provost PJ, et al. Etiologic relationship of marmonset propagated CR 326 hepatitis A virus to hepatitis in man. Proc Soc Exp Biol Med 1973; 142: 1257.

    PubMed  CAS  Google Scholar 

  95. Mandell G. Principles and practices of infectious diseases. 3rd edition. Churchhill: Livingstone 1986.

    Google Scholar 

  96. Frösner GG. Epidemiologie der Hepatitis A und E. In: Maass G, STÜCK B (Hrsg.). Virushepatitis A bis E — Diagnose, Therapie, Prophylaxe. Kilian 1994; 18–29.

    Google Scholar 

  97. Shapiro CN, et al. Epidemiology of hepatitis A infection in the United States. International symposium on viral hepatitis and liver disease. Houston 1990.

    Google Scholar 

  98. Mannucci PM. Outbreak of hepatitis A among Italian patients with haemophilia. Lancet 1992.

    Google Scholar 

  99. Moradpour D, Blum HE. Neue Heptitisviren. Internist 1996; 37: 903–911.

    PubMed  CAS  Google Scholar 

  100. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H. Hepatitis C virus: detection of intrazellular virus partiales by electron microscopy. Hepatology 1996; 23: 205–209.

    Article  PubMed  CAS  Google Scholar 

  101. Boker Khw, Manns MP. Diagnostik und Therapie chronischer Hepatitiden. Med Klinik 1995; 90 (7): 411–422.

    Google Scholar 

  102. Zeuzem S, et al. Virushepatitis C. Z Gastroenterol 1995; 33: 117–132.

    PubMed  CAS  Google Scholar 

  103. Purcell RH. Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci: USA 1994; 91: 2401–2406.

    Article  CAS  Google Scholar 

  104. Jilg W. Gründe für eine generelle Impfung gegen Hepatitis B. Dt Arztebl 1996; 93: 3122–3123.

    Google Scholar 

  105. Ohto H, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744–750.

    Article  PubMed  CAS  Google Scholar 

  106. Holland P. IX. Triennal International Symposium on Viral Hepatitis and Liver Disease. Rom 1996.

    Google Scholar 

  107. Heintges T, et al. Epidemiolgie und Klinik der chronischen Virushepatitis. Gastroenterol 1993; (Suppl. 5), 31: 42–45.

    Google Scholar 

  108. Consensus Statement of the Viral Hepatitis Prevention Board. In: Viral Hepatitis. Vol. 4. No. 1. 1995; 5–12.

    Google Scholar 

  109. Laufs R, et al. Was bedeutet der Befund HCV-Antikörper positiv? DAB 1994; 5: C- 209-C-211.

    Google Scholar 

  110. Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli Antoni AM, Plzzocolo G, Fiaccadori F. Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 1994; 20: 666–671.

    Article  PubMed  CAS  Google Scholar 

  111. DE Medina M, Schiff ER. Hepatitis C: diagnostic assays. Semin Liver Dis 1995; 15: 33–40.

    Article  PubMed  Google Scholar 

  112. Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology 1993; 18: 1338–1343.

    Article  PubMed  CAS  Google Scholar 

  113. Alter MJ, et al. The Natural History of Community-Acquired Hepatitis C in the United States. New Engl J Med 1992; 327 (27): 1899–1905.

    Article  PubMed  CAS  Google Scholar 

  114. Demitri MS, et al. HCV-Associated Liver Cancer without Cirrhosis. Lancet 1995; 345: 413–415.

    Article  CAS  Google Scholar 

  115. Mattson L, et al. Long term follow-up of chronic post-transfusion non-A, non-B hepatitis: Clinical and Histologic Outcome. Liver 1988; 8: 184–188.

    Google Scholar 

  116. Takahasi M, et al. Natural Course of Chronic Hepatitis C. Am J Gastroenterol 1993; 88 (2): 240–243.

    Google Scholar 

  117. Tremolada F, et al. Long Term Follow-up of non-A, non-B (type C) Post Transfusion Hepatitis. J Hepatol 1992; 16: 273–281.

    Article  PubMed  CAS  Google Scholar 

  118. Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995; 15: 101–109.

    Article  PubMed  CAS  Google Scholar 

  119. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Piette JC, Huraux JM, Opolon P. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291–1300.

    PubMed  CAS  Google Scholar 

  120. Mast EE, Krawczynksi K. Hepatitis E: an overview. Ann Rev Med 1996; 47: 257–266.

    Article  PubMed  CAS  Google Scholar 

  121. Zaaijer HL, Kok M, Lelie PN, Timmerman RJ, Chau K, Van Der Pal Hjh. Hepatitis E in the Netherlands: imported and endemic. Lancet 1993; 341: 826.

    CAS  Google Scholar 

  122. Fagan EA. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology 1994; 19: 1307–1312.

    Article  PubMed  CAS  Google Scholar 

  123. Simons TN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Van Sant CL, Mushawar IK. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci: USA 1995: 92: 3401–3405.

    Article  CAS  Google Scholar 

  124. Simons IN, Leary TP, Dawson GJ, Pilotmatias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushawar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564–569.

    Article  PubMed  CAS  Google Scholar 

  125. Linnen J, Wages J Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW-K, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung Skh, Thomas H, Bradley D, Margolis H, Kim JP. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505–508.

    Article  PubMed  CAS  Google Scholar 

  126. Flehmig B. In: Arbeitsmedizin im Gesundheitsdienst. Bd. 3. HOFMAN F, STÖSSEL U (Hrsg.). Gentner: Stuttgart 1988; 89–95.

    Google Scholar 

  127. Lange W, Masihi KN. Bundesgesundheitsblatt 1986; 29: 183–187.

    Google Scholar 

  128. Hofmann F, Köster D, Schrenk Ch, Wehrle G, Berthold H. Arbeitsmed Sozialmed Präventivmed 1990; 25: 76–79.

    Google Scholar 

  129. Hofmann F, Köster D, Berthold H. Arbeitsmedizinisches Hepatitis-ARisiko bei Beschäftigten im Gesundheitsdienst und im Lebensmittelbereich — Ergebnisse der südwestdeutschen Hepatitis-A-Studie In: HOFMANN F (Hrsg.). Hepatitis A in der Arbeitswelt. ecomed: Landsberg 1992.

    Google Scholar 

  130. Chriske HW. Berufliche Hepatitis-A-Risiken im Öffentlichen Dienst. In: HOFMANN F (Hrsg.). Hepatitis A in der Arbeitswelt. ecomed: Landsberg 1992.

    Google Scholar 

  131. Abdo R, Chriske HW. HAV-Infektionsrisiken im Krankenhaus, Altenheim und Kindertagesstätten. Arbeitsmedizin im Öffentlichen Dienst. Tagungsbericht. Gentner: Stuttgart 1990; 89–93.

    Google Scholar 

  132. Sänger R. Epidemiologie der Hepatitis A und ihre Bedeutung als Berufskrankheit in der ehemaligen DDR. In: HOFMANN F (Hrsg.). Hepatitis A in der Arbeitswelt. ecomed: Landsberg 1992.

    Google Scholar 

  133. Katfke N. Aktuelle Aspekte zu Hepatitis A. Mitteilungen der Bayerischen Gesellschaft für Immun-, Tropenmedizin and Impfwesen. 1992; Suppl. 9, Jahrgang 1–7.

    Google Scholar 

  134. Steffen R. Internationales Hepatitis-Symposium. Capri 1991.

    Google Scholar 

  135. Hesla PE. Hepatitis A in Norwegian troops. Vaccine, Vol. 10. 1992; Suppl. 1: 80–81.

    Google Scholar 

  136. Hoke CH, et al. Hepatitis A in the US Army: epidemiology and vaccine development. Vaccine, Vol. 10. 1992; Suppl. 1: 75–79.

    Google Scholar 

  137. Fleming B, et al. Isolierung von infektiösem Hepatitis-A-Virus aus Klärschlamm. Z Ges Hyg 1988; 34: 494–495.

    Google Scholar 

  138. Margolis H. Risk factors associated with reported cases of acute HCV in US. Viral Hepatitis 1997; Vol. 5.

    Google Scholar 

  139. Mcquillan. Hepatitis C: Transmission and Prevention. Viral Hepatitis 1997; Vol. 5.

    Google Scholar 

  140. Jilg W. Die aktive Schutzimpfung gegen Hepatitis A. Deutsches Ärzteblatt. 89. Jhrg. 1992; 41.

    Google Scholar 

  141. Leentwaar-Kujpers A, et al. Simultaneous passive and aktive immunization against hepatitis A. Vaccine, Vol. 10. 1992; Suppl. 1: 138–141.

    Google Scholar 

  142. Hattum J Van, et al. In vitro anti-HBs production by individual B cells of responders to hepatitis B vaccine who subsequently lost antibody. In: HOLLINGER FB, et al. Viral hepatitis and liver disease. Williams and Wilkins 1991; 774–776.

    Google Scholar 

  143. Carman WF, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325–329.

    Article  PubMed  CAS  Google Scholar 

  144. Taylor PE, et al. Persistence of antibody to hepatitis B surface antigen after vaccination with hepatitis B vaccine. In: ZUCKERMANN AJ. Viral hepatitis and liver disease. Alan Liss: New York 1988; 995–997.

    Google Scholar 

  145. Hadler SC, et al. Evaluation of long-term protection by hepatitis B vaccine for seven to nine years in homosexual men. In: HOLLINGER FB, et al. Viral hepatitis and liver disease. Williams and Wilkins 1991; 766–768.

    Google Scholar 

  146. Wainwright RB, et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population — Preliminary results of an 8-year study. In: Hollinger FB, et al. Viral hepatitis and liver disease. Williams and Wilkins 1991.

    Google Scholar 

  147. Courouce AM, et al. Long-term efficacy of hepatitis B vaccination in healthy adults, In: ZUCKERMANN AJ. Viral hepatitis and liver disease. Alan Liss: New York 1988; 1002–1005.

    Google Scholar 

  148. Gibas A, et al. Long-term persistence of protective antibody after hepatitis B vaccination of healthy adults. In: ZUCKERMANN AJ. Viral hepatitis and liver disease. Alan Liss: New York 1988; 998–1001.

    Google Scholar 

  149. Czeschinski Pa, Witting U. Simultanimpfung gegen Hepatitis A und B, Vergleich der Serokonversionsraten und Antikörpertiter mit denen bei Einzelimpfungen. Dokumentationsband über die Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin, 36. Jahrestagung, Wiesbaden 1996; 517–519.

    Google Scholar 

  150. Czeschinski PA. Comparative study of the efficacy of vaccination against Hepatitis A and B. In: Book of proceedings. Occupational risks and prevention. ISSA: Paris 8–9, june, 1995; 464–465.

    Google Scholar 

  151. Bruguera M, et al. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine. Vol. 14. No. 15. 1996; 1407–1411.

    Article  PubMed  CAS  Google Scholar 

  152. Ambrosch F, et al. Clinical and Immunological Investigation of a New Combined Hepatitis A and Hepatitis B Vaccine. Journal of Medical Virology 1994; 44: 452–456.

    Article  PubMed  CAS  Google Scholar 

  153. Gemeinsame Stellungnahme zum Problem der Übertragung von HIV durch Zahnärzte und Ärzte. Deutsches Ärzteblatt 1991; 88, Heft 33, A-2692–2693.

    Google Scholar 

  154. Mele A, et al. Control of hepatitis B in Italy. In: Proceedings of IX triennial international symposium on viral hepatitis and liver disease. Rome, April 2125, 1996. CpA: Rom 1996: 21.

    Google Scholar 

  155. Mele A, et al. Control of hepatitis B in Italy. In: Proceedings of IX triennial international symposium on viral hepatitis and liver disease. Rome, April2125, 199. CpA: Rom 1996: 272.

    Google Scholar 

  156. Mcmahon BJ, et al. Control of an outbreak of hepatitis A in Alaska using an inactivated hepatitis A vaccine. Abstract Volume IX triennial international symposium on viral hepatitis and liver disease. Rome, April 21–25, 1996: 361.

    Google Scholar 

  157. Prikazsky V. Interruption of an outbreak of hepatitis A in two villages by vaccination. Journal of Medical Virology 1994; 44: 457–459.

    Article  PubMed  CAS  Google Scholar 

  158. Werner H. Medizinische Mikrobiologie. Walter de Gruyter: Berlin - New York 1992.

    Google Scholar 

  159. Epidemiologisches Bulletin des Robert-Koch-Instituts 9/1997.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Arbeitsmedizin, Westfälische Wilhelms-Universität, Domagkstraße 11, 48149, Münster, Deutschland

    Dr. med. Peter Czeschinski

Authors
  1. Dr. med. Peter Czeschinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Czeschinski, P. (1998). Literaturverzeichnis. In: Die Virushepatitiden. Deutscher Universitätsverlag, Wiesbaden. https://doi.org/10.1007/978-3-663-05409-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-05409-2_13

  • Publisher Name: Deutscher Universitätsverlag, Wiesbaden

  • Print ISBN: 978-3-663-05410-8

  • Online ISBN: 978-3-663-05409-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation